Consistent with our findings of genetic deletion, increases of human AGT and renin in PTCs, with either direct increases of human AGT in PTCs (transgenic approach) or via population of human AGT in liver (AAV approach), has no effects on atherosclerosis in hypercholesterolemic mice. Here, AGT is linked to atherosclerosis.